MIRM
Mirum Pharmaceuticals, Inc.
A pharmaceutical company focused on rare diseases, it markets three FDA-approved medicines: Livmarli for the severe itching of certain inherited liver conditions, Ctexli for cerebrotendinous xanthomatosis, and Cholbam for bile acid disorders. It was founded in 2018 by a team that revived its lead drug after pharmaceutical giant Shire set it aside, and its name comes from Latin, meaning "wonder" or "marvel."
CUSIP: 604749101HealthcareUS1 holder
Total Value
$2.45M
Total Shares
20.9K
Net Share Change
+368
Activity
1 buying
Investor
Value
Shares
Weight
Change
